UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Ennis
EBF
$554M
| $614K | ﹤0.01% |
28,737
| – | – |
|
2252
Arcutis Biotherapeutics
ARQT
$3.48B
| $613K | ﹤0.01% |
+21,200
| New | +$662K |
|
2253
Sterling Infrastructure
STRL
$15.2B
| $612K | ﹤0.01% |
26,400
+13,600
| +106% | +$296K |
|
|
MYOV
2254
DELISTED
Myovant Sciences Ltd.
MYOV
| $610K | ﹤0.01% |
29,630
-10,163
| -26% | -$231K |
|
|
HONE
2255
DELISTED
HarborOne Bancorp
HONE
| $608K | ﹤0.01% |
45,116
-7,556
| -14% | -$91.9K |
|
2256
Peoples Bancorp
PEBO
$1.51B
| $605K | ﹤0.01% |
18,253
+6,934
| +61% | +$222K |
|
|
QIWI
2257
DELISTED
QIWI PLC
QIWI
| $605K | ﹤0.01% |
56,800
| – | – |
|
2258
Myers Industries
MYE
$1.24B
| $603K | ﹤0.01% |
30,526
| – | – |
|
2259
AMC Entertainment Holdings
AMC
$2.45B
| $603K | ﹤0.01% |
5,903
+768
| +15% | +$58.7K |
|
2260
A10 Networks
ATEN
$2.07B
| $602K | ﹤0.01% |
62,617
-7,596
| -11% | -$74.4K |
|
|
RC
2261
Ready Capital
RC
$260M
| $593K | ﹤0.01% |
44,165
+1,312
| +3% | +$17K |
|
2262
Horizon Bancorp
HBNC
$1.06B
| $592K | ﹤0.01% |
31,888
| – | – |
|
2263
Brown-Forman Class A
BF.A
$13.7B
| $590K | ﹤0.01% |
9,260
-2,797
| -23% | -$191K |
|
2264
Monarch Casino & Resort
MCRI
$2.2B
| $586K | ﹤0.01% |
9,664
| – | – |
|
2265
Karyopharm Therapeutics
KPTI
$155M
| $585K | ﹤0.01% |
3,708
-484
| -12% | -$102K |
|
2266
Amneal Pharmaceuticals
AMRX
$6.1B
| $585K | ﹤0.01% |
86,949
-2,656
| -3% | -$14.7K |
|
|
CTT
2267
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $584K | ﹤0.01% |
57,344
| – | – |
|
2268
Acco Brands
ACCO
$399M
| $581K | ﹤0.01% |
68,831
-35,576
| -34% | -$306K |
|
2269
Viemed Healthcare
VMD
$447M
| $581K | ﹤0.01% |
57,100
| – | – |
|
2270
SiTime
SITM
$13.8B
| $581K | ﹤0.01% |
5,888
+3,488
| +145% | +$408K |
|
2271
Lindblad Expeditions
LIND
$1.95B
| $576K | ﹤0.01% |
30,488
| – | – |
|
|
GOOD
2272
Gladstone Commercial Corp
GOOD
$623M
| $576K | ﹤0.01% |
29,438
| – | – |
|
2273
Genesco
GCO
$434M
| $576K | ﹤0.01% |
12,120
+5,367
| +79% | +$231K |
|
2274
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $575K | ﹤0.01% |
1,912
-7,122
| -79% | -$2.21M |
|
2275
CEL-SCI Corp
CVM
$19.9M
| $574K | ﹤0.01% |
1,257
+147
| +13% | +$80.3K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.